Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury
Pfizer said Monday it's scrapping development of its daily weight-loss pill, danuglipron, after a patient experienced a liver injury. The post Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury appeared first on Investor's Business Daily.
Pfizer said Monday it's scrapping development of its daily weight-loss pill, danuglipron, after a patient experienced a liver injury.
The post Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
